Olympiad Research LP Reduces Stock Position in The Allstate Co. (NYSE:ALL)

Olympiad Research LP lessened its position in shares of The Allstate Co. (NYSE:ALL) by 30.4% during the 3rd quarter, Holdings Channel reports. The firm owned 1,855 shares of the insurance provider’s stock after selling 809 shares during the quarter. Olympiad Research LP’s holdings in Allstate were worth $352,000 as of its most recent filing with the SEC.

Several other large investors have also added to or reduced their stakes in ALL. Pathway Financial Advisers LLC grew its stake in Allstate by 18,472.5% during the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock valued at $199,642,000 after purchasing an additional 1,047,019 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in Allstate by 18.7% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock valued at $569,114,000 after purchasing an additional 472,040 shares during the last quarter. AQR Capital Management LLC boosted its stake in shares of Allstate by 181.6% in the second quarter. AQR Capital Management LLC now owns 719,997 shares of the insurance provider’s stock worth $114,955,000 after buying an additional 464,337 shares during the last quarter. Acadian Asset Management LLC boosted its stake in shares of Allstate by 3,839.0% in the second quarter. Acadian Asset Management LLC now owns 416,117 shares of the insurance provider’s stock worth $66,417,000 after buying an additional 405,553 shares during the last quarter. Finally, BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its stake in shares of Allstate by 757.1% in the second quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 340,274 shares of the insurance provider’s stock worth $54,328,000 after buying an additional 300,572 shares during the last quarter. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Insider Buying and Selling

In related news, CEO Thomas J. Wilson sold 90,000 shares of the stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the transaction, the chief executive officer now directly owns 88,552 shares in the company, valued at approximately $15,880,915.68. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, EVP Robert Toohey sold 16,682 shares of the stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $180.17, for a total value of $3,005,595.94. Following the completion of the transaction, the executive vice president now directly owns 4,873 shares in the company, valued at approximately $877,968.41. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Thomas J. Wilson sold 90,000 shares of the stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the transaction, the chief executive officer now owns 88,552 shares of the company’s stock, valued at $15,880,915.68. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 192,530 shares of company stock worth $34,967,665. Company insiders own 1.80% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently commented on ALL shares. Piper Sandler upped their target price on Allstate from $188.00 to $196.00 and gave the stock an “overweight” rating in a research note on Friday, August 16th. Raymond James upped their target price on Allstate from $205.00 to $220.00 and gave the stock a “strong-buy” rating in a research note on Friday, October 4th. Bank of America increased their price target on Allstate from $216.00 to $233.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. StockNews.com downgraded Allstate from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 21st. Finally, The Goldman Sachs Group increased their price target on Allstate from $199.00 to $204.00 and gave the stock a “buy” rating in a research report on Thursday, August 15th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Allstate has an average rating of “Moderate Buy” and a consensus target price of $210.31.

Allstate Price Performance

NYSE:ALL opened at $190.55 on Friday. The Allstate Co. has a one year low of $127.93 and a one year high of $198.79. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The stock has a market cap of $50.46 billion, a PE ratio of 12.34, a P/E/G ratio of 1.71 and a beta of 0.48. The stock has a 50 day moving average price of $188.89 and a 200 day moving average price of $175.59.

Allstate (NYSE:ALL) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating the consensus estimate of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The firm had revenue of $16.63 billion during the quarter, compared to analysts’ expectations of $14.57 billion. During the same quarter last year, the firm earned $0.81 earnings per share. The business’s revenue for the quarter was up 14.7% on a year-over-year basis. Equities research analysts expect that The Allstate Co. will post 15.23 EPS for the current fiscal year.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.